市场调查报告书

抗精神病药的全球市场

Antipsychotic Drugs

出版商 Global Industry Analysts, Inc. 商品编码 956943
出版日期 内容资讯 英文 191 Pages
商品交期: 最快1-2个工作天内
价格
抗精神病药的全球市场 Antipsychotic Drugs
出版日期: 2020年09月01日内容资讯: 英文 191 Pages
简介

全球抗精神病药的市场规模在2020年~2027年的分析期间中预计将以4.1%的年复合成长率增长,从2020年的165亿美元到2027年达到218亿美元。市场区隔之一的思觉失调症部门在分析期间结束前预测将以4.2%的年率增长,达到11亿美元的规模。

本报告提供全球抗精神病药市场的相关调查,提供市场占有率,趋势和预测,成长要素,各地区的市场分析,竞争情形,主要企业的简介等资讯。

调查对象企业范例

  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline PLC
  • Pfizer, Inc.

目录

I. 简介,调查手法 、 调查范围

II. 摘要整理

  • 市场概要
    • Covid-19的影响和即将到来的全球景气衰退
    • 竞争的市场占有率
    • 竞争的市场占有率方案
  • 主要企业
  • 趋势与成长要素
  • 全球市场预测

III. 市场分析

  • 各地区市场分析
  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他中东
  • 非洲

IV. 竞争

  • 企业简介:32公司
目录
Product Code: MCP10320

Global Antipsychotic Drugs Market to Reach US$21.8 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Antipsychotic Drugs estimated at US$16.5 Billion in the year 2020, is projected to reach a revised size of US$21.8 Billion by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027.Schizophrenia, one of the segments analyzed in the report, is projected to grow at a 4.2% CAGR to reach US$1.1 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bipolar Disorder segment is readjusted to a revised 4.5% CAGR for the next 7-year period. This segment currently accounts for a 16.1% share of the global Antipsychotic Drugs market.

The U.S. Accounts for Over 28.8% of Global Market Size in 2020, While China is Forecast to Grow at a 6.8% CAGR for the Period of 2020-2027

The Antipsychotic Drugs market in the U.S. is estimated at US$4.7 Billion in the year 2020. The country currently accounts for a 28.84% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$3.8 Billion in the year 2027 trailing a CAGR of 6.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR while Rest of European market (as defined in the study) will reach US$3.8 Billion by the year 2027.

Depression Segment Corners a 47.9% Share in 2020

In the global Depression segment, USA, Canada, Japan, China and Europe will drive the 3.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$6 Billion in the year 2020 will reach a projected size of US$7.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.9 Billion by the year 2027, while Latin America will expand at a 4.2% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 191-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline PLC
  • Pfizer, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Global Competitor Market Shares
    • Antipsychotic Drugs Competitor Market Share Scenario Worldwide (in %): 2018E
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Antipsychotic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 2: World Historic Review for Antipsychotic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 3: World 15-Year Perspective for Antipsychotic Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2018 & 2027
    • TABLE 4: World Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 5: World Historic Review for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 6: World 15-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2018 & 2027
    • TABLE 7: World Current & Future Analysis for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 8: World Historic Review for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 9: World 15-Year Perspective for Bipolar Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2018 & 2027
    • TABLE 10: World Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 11: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 12: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2018 & 2027
    • TABLE 13: World Current & Future Analysis for Dementia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 14: World Historic Review for Dementia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 15: World 15-Year Perspective for Dementia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2018 & 2027
    • TABLE 16: World Current & Future Analysis for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 17: World Historic Review for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 18: World 15-Year Perspective for Other Therapeutic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Antipsychotic Drugs Market Share (in %) by Company: 2018 &
    • Market Analytics
    • TABLE 19: USA Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 20: USA Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 21: USA 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • CANADA
    • TABLE 22: Canada Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 23: Canada Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 24: Canada 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • JAPAN
    • TABLE 25: Japan Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 26: Japan Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 27: Japan 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • CHINA
    • TABLE 28: China Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 29: China Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 30: China 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Antipsychotic Drugs Market: Competitor Market Share Scenario (in %) for 2018 &
    • Market Analytics
    • TABLE 31: Europe Current & Future Analysis for Antipsychotic Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 32: Europe Historic Review for Antipsychotic Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 33: Europe 15-Year Perspective for Antipsychotic Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2018 & 2027
    • TABLE 34: Europe Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 35: Europe Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 36: Europe 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • FRANCE
    • TABLE 37: France Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 38: France Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 39: France 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • GERMANY
    • TABLE 40: Germany Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 41: Germany Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 42: Germany 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • ITALY
    • TABLE 43: Italy Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 44: Italy Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 45: Italy 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • UNITED KINGDOM
    • TABLE 46: UK Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 47: UK Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 48: UK 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • SPAIN
    • TABLE 49: Spain Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 50: Spain Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 51: Spain 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • RUSSIA
    • TABLE 52: Russia Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 53: Russia Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 54: Russia 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • REST OF EUROPE
    • TABLE 55: Rest of Europe Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 56: Rest of Europe Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 57: Rest of Europe 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • ASIA-PACIFIC
    • TABLE 58: Asia-Pacific Current & Future Analysis for Antipsychotic Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 59: Asia-Pacific Historic Review for Antipsychotic Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 60: Asia-Pacific 15-Year Perspective for Antipsychotic Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2018 & 2027
    • TABLE 61: Asia-Pacific Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 62: Asia-Pacific Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 63: Asia-Pacific 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • AUSTRALIA
    • TABLE 64: Australia Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 65: Australia Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 66: Australia 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • INDIA
    • TABLE 67: India Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 68: India Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 69: India 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • SOUTH KOREA
    • TABLE 70: South Korea Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 71: South Korea Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 72: South Korea 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 73: Rest of Asia-Pacific Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 74: Rest of Asia-Pacific Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 75: Rest of Asia-Pacific 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • LATIN AMERICA
    • TABLE 76: Latin America Current & Future Analysis for Antipsychotic Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 77: Latin America Historic Review for Antipsychotic Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 78: Latin America 15-Year Perspective for Antipsychotic Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2018 & 2027
    • TABLE 79: Latin America Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 80: Latin America Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 81: Latin America 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • ARGENTINA
    • TABLE 82: Argentina Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 83: Argentina Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 84: Argentina 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • BRAZIL
    • TABLE 85: Brazil Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 86: Brazil Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 87: Brazil 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • MEXICO
    • TABLE 88: Mexico Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 89: Mexico Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 90: Mexico 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • REST OF LATIN AMERICA
    • TABLE 91: Rest of Latin America Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 92: Rest of Latin America Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 93: Rest of Latin America 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • MIDDLE EAST
    • TABLE 94: Middle East Current & Future Analysis for Antipsychotic Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through
    • TABLE 95: Middle East Historic Review for Antipsychotic Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 96: Middle East 15-Year Perspective for Antipsychotic Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2018 & 2027
    • TABLE 97: Middle East Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 98: Middle East Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 99: Middle East 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • IRAN
    • TABLE 100: Iran Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 101: Iran Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 102: Iran 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • ISRAEL
    • TABLE 103: Israel Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 104: Israel Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 105: Israel 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • SAUDI ARABIA
    • TABLE 106: Saudi Arabia Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 107: Saudi Arabia Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 108: Saudi Arabia 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 109: UAE Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 110: UAE Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 111: UAE 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • REST OF MIDDLE EAST
    • TABLE 112: Rest of Middle East Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 113: Rest of Middle East Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 114: Rest of Middle East 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027
  • AFRICA
    • TABLE 115: Africa Current & Future Analysis for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through
    • TABLE 116: Africa Historic Review for Antipsychotic Drugs by Therapeutic Application - Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through
    • TABLE 117: Africa 15-Year Perspective for Antipsychotic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Schizophrenia, Bipolar Disorder, Depression, Dementia and Other Therapeutic Applications for the Years 2012, 2018 & 2027

IV. COMPETITION

  • Total Companies Profiled: 32